My name is Hao Chi, MD, and I am currently a Professor affiliated with Southwest Medical University in Luzhou, China. As an established researcher in oncology, my work focuses on understanding tumor biology, particularly mechanisms of programmed cell death, immune microenvironment interactions, and therapy resistance in cancer. I am deeply committed to uncovering these mechanisms to enhance cancer prognosis and treatment outcomes, driven by the desire to improve patient care and advance personalized medicine. My expertise in advanced bioinformatics and machine learning enables me to analyze complex multi-omics datasets, revealing novel biomarkers and therapeutic targets. Utilizing high-throughput sequencing and single-cell technologies, I dissect the molecular and cellular heterogeneity of tumors, providing insights into immune landscape characteristics crucial for prognostication. What sets me apart is my integration of computational and experimental approaches, allowing me to tackle complex cancer-related challenges from both biological and data-driven perspectives. My contributions have earned recognition within the global scientific community, as reflected in my placement in the top 2% of the world’s scientists, and have been validated by over 1,300 citations and an H-index of 25. Through editorial roles and peer reviews, I actively contribute to maintaining high standards in scientific publishing and disseminating impactful oncology research. I have published over 100 peer-reviewed articles, with numerous first-author and corresponding-author publications in high-impact journals such as Frontiers in Immunology and Frontiers in Oncology. My work has garnered more than 1,350 citations, achieving an H-index of 25 on Google Scholar. I have been invited to present my research at over 10 international academic conferences, highlighting my findings on immune microenvironment and cancer prognostication. Recognized in the top 2% of the world's leading scientists for 2024, I also hold editorial positions with multiple journals, including Cancer Control, Medical Oncology, and BMC Cancer, where I contribute to advancing the field of oncology. Additionally, I actively review for reputable journals such as Cancer Letters and Scientific Reports, underscoring my commitment to the integrity of scientific research. My academic accomplishments and influence reflect my dedication to progressing cancer research and providing innovative therapeutic insights to the scientific and medical communities worldwide. I have actively contributed to the academic community by peer reviewing over 50 manuscripts for leading journals, such as Cancer Letters, Frontiers in Immunology, and Scientific Reports, ensuring the quality and rigor of published research. Additionally, I have authored or co-authored more than 10 editorials in high-impact journals, including Frontiers in Immunology and Frontiers in Molecular Biosciences, where I provided expert commentary on emerging topics such as tumor microenvironment and immune response in oncology. My editorial experience further includes serving on the boards of Cancer Control, Medical Oncology, and BMC Cancer, where I help shape the scope and direction of published oncology research. Through these roles, I contribute to advancing the quality and impact of scientific literature in my field. My professional goal is to drive transformative advances in cancer treatment and prognosis by elucidating the molecular underpinnings of tumor biology. My long-term research focuses on understanding programmed cell death mechanisms, the immune microenvironment, and therapy resistance in cancers, aiming to discover biomarkers and therapeutic targets that facilitate precision oncology. I am particularly interested in leveraging bioinformatics and machine learning to analyze multi-omics data, with the goal of unveiling complex cellular interactions within tumors that can inform personalized treatment strategies. By contributing novel insights and fostering collaborations, I strive to enhance patient outcomes and contribute meaningfully to the global fight against cancer. I possess a well-rounded skill set that complements my technical expertise, including strong active listening and communication skills, which allow me to effectively collaborate and exchange ideas within diverse research teams. My interpersonal and mentoring skills have been instrumental in guiding junior researchers, fostering a supportive environment that encourages scientific curiosity and growth. I also have demonstrated leadership and management capabilities, particularly in overseeing complex research projects and coordinating interdisciplinary collaborations to address key challenges in oncology. My problem-solving skills are essential in tackling complex research questions, especially as I integrate advanced bioinformatics and experimental data to uncover novel insights in cancer biology. Through these combined skills, I am able to lead impactful projects and contribute to advancing cancer research in meaningful ways. in my free time, I enjoy hiking, reading scientific literature, and exploring data visualization techniques, which help me stay active, continuously expand my knowledge, and fuel my passion for integrating creativity into research.